Good article but as I mentioned in my earlier post, they're only estimating FY EPS of 4.2c when 1H EPS was 2.2c. Does the companies comments about "market seasonality" mean they expect the second half numbers to be worse than first half?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025